DPL logo

Dipna Pharmachem Ltd

DPL·BSE·
5.51 -0.29 (-5.00%)
Market Cap14.54 Cr
PE Ratio13.77
Volume75,000
Day High - Low5.93 - 5.51
52W High-Low25.00 - 3.90
DocStoX Score
5.1/10
Weak
Fair Value
Sign in to see
ROE
5.22%
Weak
P/E
13.77x
Cheap
Debt / Equity
0.21
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day5.51
5.93
52W3.90
25.00
DocStoX take

Supported by valuation (9.0) and growth (8.5), but held back by momentum (0.0). Valuation looks strong at 9.0, but that is offset by momentum at 0.0 and quality at 2.2. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.1
/10
Weak
Quality
Weak
ROE 5.2%
Valuation
Cheap
P/E 13.8×
Growth
Strong
Revenue +33.0% 5Y CAGR
Risk
Moderate
D/E 0.21
Momentum
Weak
8% of 52-week range

At a glance

Market Cap
₹15 Cr
52W High / Low
₹25 / ₹4
Dividend Yield
0.00%
Promoter Holding
9.13%
EPS (TTM)
₹0.40
Book Value
₹23.70

Key highlights

  • Profit compounding 38% a year
  • Revenue compounding 33% a year
  • Low leverage — D/E 0.21
  • Quality is weak (2.2/10)
  • Momentum is weak (0.0/10)
4 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Dipna Pharmachem Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Dipna Pharmachem Ltd (DPL) Share Price at ₹5.51 (-5.00%) | DocStoX